PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients
Cells · 2024
DOI: 10.3390/cells13171444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Junyue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea. Hauptthemen laut MEDLINE: Osteosarcoma, B7-H1 Antigen, Drug Resistance, Neoplasm, Doxorubicin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…, the R&D Program of the Ministry of Trade, Industry and Energy/Korea Evaluation Institute of Industrial Technology, Ministry of Health & Welfare.
Abstract (Originalsprache)
PAK4 and PD-L1 have been suggested as novel therapeutic targets in human cancers. Moreover, PAK4 has been suggested to be a molecule closely related to the immune evasion of cancers. Therefore, this study evaluated the roles of PAK4 and PD-L1 in the progression of osteosarcomas in 32 osteosarcomas and osteosarcoma cells. In human osteosarcomas, immunohistochemical positivity for the expression of PAK4 (overall survival, p = 0.028) and PD-L1 (relapse-free survival, p = 0.002) were independent indicators for the survival of patients in a multivariate analysis. In osteosarcoma cells, the overexpression of PAK4 increased proliferation and invasiveness, while the knockdown of PAK4 suppressed proliferation and invasiveness. The expression of PAK4 was associated with the expression of the molecules related to cell cycle regulation, invasion, and apoptosis. PAK4 was involved in resistance to apoptosis under a treatment regime with doxorubicin for osteosarcoma. In U2OS cells, PAK4 was involved in the stabilization of PD-L1 from ubiquitin-mediated proteasomal degradation and the in vivo infiltration of immune cells such as regulatory T cells and PD1-, CD4-, and CD8-positive cells in mice tumors. In conclusion, this study suggests that PAK4 is involved in the progression of osteosarcoma by promoting proliferation, invasion, and resistance to doxorubicin and stabilized PD-L1 from proteasomal degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea.
- Department of Bio and Chemical Engineering, Hongik University, Sejong 30016, Republic of Korea.
- Department of Biochemistry and Molecular Biology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea.
- Department of Orthopedic Surgery, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
- Research Institute of Clinical Medicine, Jeonbuk National University, Jeonju 54896, Republic of Korea.
- Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
ORCID-Profile: Junyue Zhang, Ho Sung Park, See-Hyoung Park, Young Jae Moon, Kyu Yun Jang
Förderung
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…
- the R&D Program of the Ministry of Trade, Industry and Energy/Korea Evaluation Institute of Industrial Technology
- Ministry of Health & Welfare
- Ministry of Trade, Industry and Energy/Korea Evaluation Institute of Industrial Technology
Zitieren
APA
Zhang, J., Song, Y., Ahn, A. R., Park, H. S., Park, S. H., Moon, Y. J., Kim, K. M., & Jang, K. Y. (2024). PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients. Cells. https://doi.org/10.3390/cells13171444
Vancouver
Zhang J, Song Y, Ahn AR, Park HS, Park SH, Moon YJ, et al. PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients. Cells. 2024. doi:10.3390/cells13171444
BibTeX
@article{Zhang2024,
author = {Zhang, Junyue and Song, Yiping and Ahn, Ae-Ri and Park, Ho Sung and Park, See-Hyoung and Moon, Young Jae and Kim, Kyoung Min and Jang, Kyu Yun},
title = {PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13171444}
}
EUVIMED